Valve-sparing root replacement in children with connective tissue disease: Long-term risk of aortic events

Ilkun Park1, Ji-Hyuk Yang1, Kiick Sung1

  • 1Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Insights

Valve-sparing root replacement (VSRR) in pediatric patients with connective tissue disease (CTD) shows good long-term survival. Careful surveillance is needed for later aortic aneurysm or dissection, especially in younger patients receiving VSRR.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Connective Tissue Diseases

Background:

  • Cardiovascular involvement, particularly aortic root dilatation, is a life-threatening complication in pediatric connective tissue diseases (CTD).
  • Valve-sparing root replacement (VSRR) is a surgical option for aortic root dilatation in this population.

Purpose of the Study:

  • To evaluate the long-term outcomes of VSRR in pediatric patients with CTD.
  • To assess reoperation rates for aortic aneurysm and dissection following VSRR.

Main Methods:

  • Retrospective analysis of pediatric CTD patients undergoing VSRR (2002-2021).
  • Primary endpoint: composite of all-cause death and cardiovascular reoperations.
  • Median follow-up of 8.3 years.

Main Results:

  • 15-year survival rate was 91.7% in 24 pediatric patients (median age 14.4 years).
  • 10-year cumulative incidence of reoperation for aortic regurgitation was 15.6%; for aneurysm/dissection, it was 29.1%.
  • Younger age at surgery and VSRR before 13 years were independent predictors of adverse events.

Conclusions:

  • VSRR offers good long-term survival and low reoperation for aortic regurgitation in pediatric CTD.
  • Later aortic aneurysm or dissection can occur, necessitating vigilant surveillance.
  • Younger patients undergoing VSRR require particular attention during follow-up.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
22
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
11
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
9